Is GENE a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

606 people get GENE articles and Market Currents by email alert.

Get email alerts on GENE »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Genetic Technologies Moving On News This Morning
Markus Aarnio • Wed, Aug 8, 2012

To learn more about Seeking Alpha Pro, click here.

Don't Believe The Stories That The Markets Are Down Today
Richard Berger • Tue, Apr 16 • 36 Comments
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
3 Best Biotech Stocks For This Week (Part VI)
Jorge Aura • Tue, Oct 16, 2012 • 4 Comments
Smaller Cap Biopharma News And Events For Tuesday, September 25
Scott Matusow • Tue, Sep 25, 2012 • 12 Comments
3 Biotech Stocks On The Move
Jessica King Holden • Tue, May 22, 2012 • 2 Comments
5 High-Flying Small Caps: What To Expect In 2012
Brian Nichols • Wed, Nov 23, 2011 • 5 Comments
The Micro-Cap Superstars
Ian Cassel • Fri, Oct 21, 2011 • 3 Comments
6 Stocks Shining on Monday
Alex Shadunsky • Tue, Jul 12, 2011
The Complete List of Australian ADR Stocks
David Hunkar • Fri, Nov 6, 2009 • 6 Comments
Australian Stocks: 14 Ways to Invest Down Under
Stockerblog • Thu, Jun 21, 2007 • 2 Comments
Capital Flow Away From Large-cap US Companies Continues
• Tue, Apr 4, 2006

There are no Transcripts on GENE.

STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE

GlobeNewswire (Apr 15, 2013)
The Centers for Women's Health in Stamford CT Pioneers Breast Cancer Risk Assessment

GlobeNewswire (Mar 18, 2013)
Movers & Shakers: Tuesday’s biggest gaining and declining stocks

at MarketWatch.com (Sep 25, 2012)
Movers & Shakers: Friday’s top gaining and declining stocks

at MarketWatch.com (May 25, 2012)
Movers & Shakers: Tuesday’s biggest gaining and declining stocks

at MarketWatch.com (May 22, 2012)

GENE vs. ETF Alternatives

Company Description

Currently, there's no company description for GENE.

Sector: Healthcare

Industry: Biotechnology

Country: Australia

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, June 19, 11:35 AM Genetic Technologies (GENE -1.1%) says its subsidiary Phenogen Sciences has executed an agreement with FedMed to use its national provider network. FedMed's network includes more than 550K, 60K ancillary care providers and 4K hospitals nationwide, with more than 40M covered individuals. Comment! [Healthcare, On the Move]
Tuesday, June 18, 12:45 PM Midday top 10 gainers: USMD +31%. ZN +26%. GEVO +23%. CBMX +21%. CYTK +20%. PRXI +18%. HOTR +18%. WLT +15%. BBGI +15%. ATV +14%.
Midday top 10 Losers: OSH -14%. MNKD -13%. OPXA -12%. LTON -10%. IESC -10%. KNDI -9%. FRO -8%. GENE -8%. BAA -8%. HAST -8%. Comment! [On the Move]
Wednesday, May 15, 3:22 PM Gene-related stocks are getting a big bump today on the back of Angelina Jolie's recent decision to have a mastectomy to prevent possible breast cancer: Rosetta Genomics (ROSG +15.5%), Genetic Technologies (GENE +12.9%), Diagnocure (DGCRF.PK +12%), GeneNews (GNSWF.PK +5%). Myriad Genetics (MYGN -2.2%) is lower on a bout of profit-taking, possibly exacerbated by news of some insider selling today by its CEO as well. Comment! [Healthcare, On the Move]
Friday, May 3, 8:36 AM Genetic Technologies (GENE) rises 21% premarket after saying it has executed an agreement with a fifth PPO, allowing the company's BREVAGen test to be adjudicated "in network," where reimbursement is 25% higher and collection times are "materially shorter." (PR) Comment! [On the Move, Healthcare]
Tuesday, April 16, 12:59 PM Midday top 10 gainers: UNXL +16%. CNIT +15%. ANEN +15%. CHCI +14%. SYNM +13%. PNFP +12%. EVC +12%. ENPH +11%. NCQ +11%. ACOR +11%.
Midday top 10 losers: JAXB -33%. KEYN -15%. SRPT -12%. CPGI -10%. GENE -10%. TRIT -9%. CCXI -9%. MAGS -9%. ADAT -8%. GAI -8%. Comment! [On the Move]
Monday, April 15, 12:50 PM Midday top 10 gainers: MKTAY +143%. CNIT +21%. GENE +21%. THRX +18%. MCOX +17%. SGRP +14%. S +13%. STXS +10%. ACOR +9%. LIFE +8%.
Midday top 10 losers: UNTK -48%. GSS -19%. ASM -18%. DSCO -17%. HXM -16%. XPL -16%. NGD -16%. TGD -15%. BAA -14%. PZG -14%. Comment! [On the Move]
Monday, December 10, 2012, 11:32 AM Genetic Technologies (GENE -0.9%) slips this morning after the company names its COO and acting Chief Executive Alison Mew as its permanent CEO, less than two weeks after its former head, Paul MacLeman - along with several other company executives - resigned. Last month Mr. MacLeman stepped down in protest after GENE's founder, Mervyn Jacobson, used his 29% stake in the company to block the re-election of Chairman Mel Bridges. Comment! [Healthcare, On the Move]
Wednesday, November 28, 2012, 12:45 PM Midday top 10 gainers: VRML +34%. SHS +32%. GMCR +24%. SPMD +18%. TROV +17%. GPOR +16%. IDIX +15%. TSL +15%. KCG +14%. AXR +12%.
Midday top 10 Losers: UTI -24%. CLUB -21%. CFNB -16%. GENE -15%. TFM -14%. CBAK -13%. SBGI -12%. DWCH -13%. NFEC -11%. CAP -9%. 2 Comments [On the Move]
Wednesday, November 28, 2012, 9:30 AM Genetic Tech (GENE) plunges 20% following a management earthquake at its annual meeting. The trouble started when Genetic founder Mervyn Jacobson used his 29% stake to block the re-election of chairman Mel Bridges, with a motion to re-elect fellow director Huw Jones also failing. CEO Paul MacLeman then resigned, as did director Greg Brown and legal head David Sparling. Comment! [On the Move, Healthcare]
Wednesday, October 3, 2012, 9:10 AM Premarket gainers: SRPT +107%. BIOL +14%. GENE +13%. ROYL +9%.
Losers: XRTX -9%. ATRS -7%. RIGL -6%. Comment! [On the Move]
Tuesday, September 25, 2012, 12:45 PM Midday top 10 gainers: PPHM +42%. ECBE +35%. TGAL +21%. GENE +20%. MTN +12%. SVA +12%. PFSW +12%. UCFC +11%. NTIC +11%. SVN +11%.
Top 10 Losers: GEVO -32%. MACK -19%. OMEX -19%. DAEG -17%. SWSH -16%. DLGC -12%. KEG -12%. IOT -11%. RSH -10%. CGNX -10%. Comment!
Tuesday, September 25, 2012, 9:10 AM Premarket gainers: GENE +14%. DARA +13%. PPHM +8%. ATRS +8%. PURE +6%. UDRL +6%. ROSG +6%.
Losers: GEVO -16%. TSLA -8%. KEG -8%. Comment! [On the Move]
Tuesday, September 25, 2012, 9:05 AM Genetic Technologies (GENE) +13.1% premarket after announcing its breast cancer treatment BREVAGen has been cleared for sale in Florida. The news follows approval of the drug for California in July. GENE says Florida and California combined represent 15%-20% of breast cancer incidence in the U.S. Comment! [Healthcare, On the Move]
Thursday, September 6, 2012, 2:37 PM Australian diagnostic firm Genetic Technologies (GENE +6%) spikes higher after signing a license agreement with Conexio Genomics. Under the terms of the agreement, Conexio will be granted non-exclusive rights to a number of GENE patents relating to its non-coding DNA technology. Comment! [Healthcare, On the Move]
Wednesday, August 29, 2012, 12:23 PM Shares of Australian diagnostic firm Genetic Technologies (GENE +33%) are ripping today on the back of a new bullish report issued by Australian investment bank Lodge Partner, starting the shares with a Buy and an aggressive $17 price target (that would make it a four-bagger from current levels). The firm says BREVAGen, GENE's key diagnostic product, is regaining momentum, noting that H2 sales rose 230% over H1, and it expects that trend to continue. 1 Comment [Healthcare, Global & FX, On the Move]
Wednesday, August 8, 2012, 9:43 AM Shares of Genetic Technologies (GENE +7.6%) surge on news the genetic testing company received European CE Mark approval for BREVAGen, GENE’s breast cancer risk test. The designation will allow the test to be sold in the EU and other countries that recognize the CE Mark. Initial commercial focus will be in France and Germany. Comment! [Healthcare, On the Move]

Michael Bryant
Genetic Technologies (GENE) soared 26%. Don't forget competitor Complete Genomics (GNOM).
6/18/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Genetic Technologies (GENE) soaring again. Looks like biotech is the only thing rising these days. http://on.mktw.net/JMG7Xr
5/24/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
RT @Bullogic: 2/7 Video Watchlist PRMW GENE IPSU SYSW SOL CLSN TPLM SCHS CXPO CKP CBG EGHT BMTI ZOOM LEE http://bit.ly/xo5y8p
2/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Wow. So what's up with Genetic Technologies (GENE). It like surged 1000% and then came back down.
8/1/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

vectorpete
Can anyone provide some research links for GENE? Pleasantly surprised, but would like to figure out if things are going to turn downward!
7/17/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Watch Genetic Technologies (GENE). Something is up.
7/11/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joshua Hayes
It continues to be all about medical stocks on the long side. How about GENE today! On the other end-JVA very very parabolic. Time to short.
7/11/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Joshua Hayes
Its all about medical stocks. Some beautiful bases and breakouts out there: CBST GENE DEPO OSUR PSTI UPI COO WCG MODL ZOLL BIIB DVAX ELGX
7/7/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Robert Weinstein
shorting $GENE at 8.87 and higher for next 30 mins with a profit target of 45 cents of ave
5/2/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Soaring: Genetics biotech GENE up 67% on 75x volume to $2.50. No news sparking the move--possible takeover? Co is cash-rich.
1/10/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

GENE GENETIC TECHNOLOGIES LTD

GENE

GENETIC TECHNOLOGIES LTD